AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 101 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NewEdge Advisors, LLC | 1,300 | $13,390 | 0.00% |
| RHUMBLINE ADVISERS | 1,256 | $12,936 | 0.00% |
| UBS Group AG | 11,434 | $117,771 | 0.00% |
| CITIGROUP INC | 2,630 | $27,089 | 0.00% |
| SALEM INVESTMENT COUNSELORS INC | 450 | $4,635 | 0.00% |
| JANE STREET GROUP, LLC | 21,680 | $223,304 | 0.00% |
| MORGAN STANLEY | 437,056 | $4,501,683 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 500 | $5,150 | 0.00% |
| WOLVERINE TRADING, LLC | 33,400 | $344,020 | 0.00% |
| WOLVERINE TRADING, LLC | 15,300 | $157,590 | 0.00% |
| WOLVERINE TRADING, LLC | 14,792 | $152,358 | 0.00% |
External links
This page lists AVADEL PHARMACEUTICALS PLC's shareholders in Q3 2023. To view AVADEL PHARMACEUTICALS PLC's shareholder history, click here.